Perspectives and cases
-
All
-
CEO & Board
-
Research & Development
-
Commercial & Medical
Developing a global portfolio strategy for immunology assets, incl. product positioning and customer-centric shift.
Identifying strategic opportunities for ecosystem integration and establishing pipeline of external innovation in globally leading innovation hotspots.
Developing global TA strategy for reproductive medicine setting future direction for the portfolio as approved by the client’s executive management and Board.
Designed scalable global-to-local model to drive customer engagement and value realisation at global scale.
Assessed hsCRP testing landscape readiness across European markets, identifying critical gaps, and recommending targeted TA development initiatives.
Clarifying Medical value drivers across functions and roles and structuring strategic choices for delivering society engagement, congress engagement, and RWE.
Designing future-ready lab workflows to accelerate innovation, unlock productivity, and build flexibility into next generation R&D workflows and capability delivery.
Designing global Digital Hub operating model, delivering content and automation services to all markets globally.
Improving the standard of care with a leading immunology brand and identifying where the next wave of patient and commercial value is unlocked.
Assessing and redesigning global clinical organisation across 50+ countries to improve trial timelines and unlock efficiencies via focusing of resources.
Assessing and redesigning global clinical organisation across 50+ countries to improve trial timelines and unlock efficiencies via focusing of resources.
Developing a resource planning framework to empower global leaders to anticipate future resource demands and take deliberate action based on scenarios.
Recommending levers to unlock productivity gains in clinical operations based on analysis of front- and back-office roles and performance management practices.
Driving global roll-out of new organisational structures and ways of working, supporting global, regional, and local leaders execute across workstreams.
Developing global TA strategy for reproductive medicine setting future direction for the portfolio as approved by the client’s executive management and Board.
Moving from omnichannel ambition to execution via fit-for-purpose global-local operating model design and roll-out across markets.
Who we are
Our team of life science strategists blends international experience and backgrounds from MDs, PhDs, and top-tier strategy consulting. We engage with a structured and collaborative approach to develop practical solutions to complex problems. Meet our team of experienced life science consultants.
- Partners
- Board of Directors
- Team
Daniel works with life science executives to design strategies, operating models, and transformation programs. He brings both functional depth and board-level perspectives, helping senior leaders navigate complexity and make clear choices. He formerly led the life science practice at Deloitte Denmark.
Book Meeting
Jonas is a life science strategist supporting executives drive progress across the value chain. He is an expert in bridging strategy and execution via global operating model design and transformation rooted in strategic objectives. He engages with structured top-down thinking and a pragmatic and collaborative approach to mobilise organizations and make things happen.
Book Meeting
Jens is a seasoned strategy advisor with 30 years of experience in management consulting. Former Head of Monitor Deloitte Denmark, he brings deep expertise in shaping corporate agendas, TA strategies, operating model design, digital and AI value creation, and M&A for leading global corporations.
Book Meeting
Nicolai is a seasoned management consultant with over 20 years of experience working with C-suite executives at Danish C25 companies. He has held several leadership roles, including Senior Partner and Nordic Lead for Monitor Deloitte and Managing Director of Accenture Denmark.
Book Meeting
Alexander has 25 years of experience as an international strategy and communications advisor, supporting C-suite leaders at global biopharmaceutical companies on life science branding, digital strategy, and commercialisation. He is founder of the strategic advisory firm &Now, and co-founder of the communications firm REPUTATION.
Book Meeting
Camilla brings nearly 30 years of global pharmaceutical leadership, holding senior roles at AstraZeneca, Novartis, Allergan, Alexion, Theramex, and most recently EVP, President, International at Ascendis. Her career spans global commercial and executive leadership roles.
Book Meeting
Florian combines experience from strategy consulting and the pharmaceutical industry with a background in Economics from CBS. Recognised for structured problem-solving and a collaborative approach, he supports clients on strategic topics across the pharmaceutical value chain.
Book Meeting
Johannes has 7+ years of experience in strategy consulting and has strong expertise in TA strategy, organisational transformations, operating model design, and commercial launch planning.
Johannes holds an M.Sc. in Economics from the University of Copenhagen.
Book Meeting
Mette blends medical expertise with strategic experience as a medical doctor and former strategy consultant. Before joining Biobridge Partners, she worked at Bain & Company and LEO Innovation Lab. She focuses on cross-functional engagement in medical and commercial functions in pharma.
Book Meeting
Alfred is a seasoned life science strategy consultant with a background from Monitor Deloitte and 3+ years’ experience helping clients articulate and assess strategies, develop strategic options, and translate strategic intent into actionable plans.
Book Meeting
Josephine holds M.Sc. degrees in Biochemistry (University of Copenhagen) and Bioscience Enterprise (UCL), combining life science expertise with business. She has prior consulting experience at Bain & Company, advising clients across multiple industries.
Book Meeting
Amadou brings a cross-disciplinary background in Biotechnology and Business Administration. He has experience in strategic projects spanning the full pharmaceutical value chain, from early research to development and commercial strategy.
Book Meeting
Daniell leads marketing at Biobridge Partners, helping shape the firm’s positioning, narrative, and go-to-market execution across brand and thought leadership. He brings a background in design and concept development, including experience as a product designer on the health app SELF and 3 years leading marketing at BASE life science.
Book Meeting
Caroline brings a strong international background and a passion for life science and its potential for impact. She is pursuing a B.Sc. in International Business at CBS, with a growing focus on strategy, market access, and business development in the life sciences sector.
Book Meeting
Anton is a life science strategy consulting intern with a cross-disciplinary background in molecular medicine and business administration. He has hands-on experience in gene and cell therapy research and focuses on translating scientific innovation into real-world impact through strategic insight.
Book Meeting
Bertram brings prior experience in life science and a strong interest in strategy and business development. He is pursuing a B.Sc. in International Business at CBS, with a focus on market entry and growth topics within the life sciences sector.
Book MeetingExplore our services
We help CEOs and boards cut through the noise and make winning choices that deliver long-term value in an ever-evolving life science landscape.
Read More
We partner with R&D leaders to build strategies and operating models that combine people and technology to accelerate pipelines from early discovery through clinical trials.
Read More
We work shoulder-to-shoulder with global commercial and medical teams to address unmet needs and ensure innovation benefits healthcare systems and patients.
Read More